Related Experiment Video
Updated: Dec 14, 2025

03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.2K
A new dawn for eosinophils in the tumour microenvironment
Sharon Grisaru-Tal1, Michal Itan1, Amy D Klion2
1Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.
Nature Reviews. Cancer
|July 18, 2020
Summary
Eosinophils, key in allergies, also impact cancer. They can fight tumors or promote growth by interacting with cancer cells and the tumor microenvironment (TME).
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Eosinophils are versatile immune cells with crucial roles in allergic responses.
- These cells infiltrate tumors and influence cancer progression through direct interactions and by modulating the tumor microenvironment (TME).
Purpose of the Study:
- To provide a comprehensive overview of eosinophil biology relevant to their function within the TME.
- To examine eosinophil homing mechanisms, their dual pro- and anti-tumorigenic roles, and their potential in cancer immunotherapy.
Main Methods:
- Literature review and synthesis of existing research on eosinophil function in cancer.
- Analysis of mechanisms governing eosinophil recruitment and activity in the tumor microenvironment.
- Review of data on eosinophils as biomarkers and therapeutic targets in cancer immunotherapy.
Main Results:
- Eosinophils exhibit context-dependent functions in cancer, capable of both promoting tumor growth and mediating anti-tumor immunity.
- Their secreted molecules, including granule proteins and soluble mediators, can directly affect tumor cells and remodel the TME.
- Eosinophils show promise as predictive biomarkers and effector cells, particularly in response to immune checkpoint blockade therapy.
Conclusions:
- Eosinophils possess multifaceted roles in cancer, influencing tumor progression and response to therapy.
- Understanding eosinophil biology in the TME is crucial for developing novel cancer treatments and immunotherapies.
- Further research is needed to fully elucidate eosinophil functions and harness their potential in clinical oncology.
Related Concept Videos
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.5K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.5K
Mitogens and the Cell Cycle
7.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
Tumor Immunotherapy
1.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
Regulation of Angiogenesis and Blood Supply
3.2K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K

